Relations (1)
Facts (3)
Sources
Neuroimaging in psychedelic drug development: past, present, and ... nature.com 1 fact
referenceF.X. Vollenweider, M.F.I. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, and D. Hell published 'Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action' in NeuroReport in 1998.
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 1 fact
claimKetamine and psilocybin have both been used as experimental models of psychosis.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua 1 fact
referenceVollenweider et al. published 'Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis' in Neuropsychopharmacology, which utilizes PET and FDG to study the psilocybin model of psychosis.